Abstract
Virologic surveillance is essential to the success of the World Health Organization initiative to eradicate poliomyelitis. Molecular methods have been used to detect polioviruses in tissue culture isolates derived from stool samples obtained through surveillance for acute flaccid paralysis. This chapter describes the use of realtime PCR assays to identify and serotype polioviruses. In particular, a degenerate, inosine-containing, panpoliovirus (panPV) PCR primer set is used to distinguish polioviruses from NPEVs. The high degree of nucleotide sequence diversity among polioviruses presents a challenge to the systematic design of nucleic acid-based reagents. To accommodate the wide variability and rapid evolution of poliovirus genomes, degenerate codon positions on the template were matched to mixed-base or deoxyinosine residues on both the primers and the TaqMan™ probes. Additional assays distinguish between Sabin vaccine strains and non-Sabin strains. This chapter also describes the use of generic poliovirus specific primers, along with degenerate and inosine-containing primers, for routine VP1 sequencing of poliovirus isolates. These primers, along with nondegenerate serotype-specific Sabin primers, can also be used to sequence individual polioviruses in mixtures.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hull H et al (1994) Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 343(8909):1331–1337
Organization WH (2008) Progress towards interrupting wild poliovirus transmission worldwide, January 2007-April 2008. Wkly Epidemiol Rec 83(19):170–177
van der Avoort HG et al (1995) Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol 33(10):2562–2566
da Silva EE et al (1991) Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology 32(3):149–159
De L et al (1995) Identification of vaccine-related polioviruses by hybridization with specific RNA probes. J Clin Microbiol 33(3):562–571
Yang CF et al (1991) Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res 20(2):159–179
Yang CF et al (1992) Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res 24(3):277–296
Kew BK et al (1984) Applications of oligonucleotide fingerprinting to the identification of viruses. Methods Virol 8:41–84
Kew OM et al (1995) Molecular epidemiology of polioviruses. Semin Virol 6(6):401–414
Balanant J et al (1991) The natural genome variability of poliovirus analyzed by a restriction fragment length polymorphism assay. Virology 184(2):645–654
Schweiger B et al (1994) Differentiation of vaccine and wild-type polioviruses using polymerase chain reaction and restriction enzyme analysis. Arch Virol 134(1–2):39–50
Melnick J (1990) Poliomyelitis. In: Warren K, Mahmoud A (eds) Tropical and geographical medicines, 2nd edn. McGraw-Hill, New York, pp 558–576
Mertens T, Pika U, Eggers HJ (1983) Cross antigenicity among enteroviruses as revealed by immunoblot technique. Virology 129(2):431–442
Emini E et al (1985) Antigenic conservation and divergence between the viral-specific proteins of poliovirus type 1 and various picornaviruses. Virology 140(1):13–20
Hyypia T, Auvinen P, Maaronen M (1989) Polymerase chain reaction for human picornaviruses. J Gen Virol 70:3261–3268
Olive DM et al (1990) Detection and differentiation of picornaviruses in clinical samples following genomic amplification. J Gen Virol 71(9):2141–2147
Abraham R et al (1993) Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine. J Infect Dis 168(5):1105–1109
Egger D et al (1995) Reverse transcription multiplex PCR for differentiation between polio- and enteroviruses from clinical and environmental samples. J Clin Microbiol 33(6):1442–1447
Hovi T, Stenvik M (1994) Selective isolation of poliovirus in recombinant murine cell line expressing the human poliovirus receptor gene. J Clin Microbiol 32(5):1366–1368
Kilpatrick DR et al (1996) Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol 34(12):2990–2996
Minor PD et al (1986) Antigenic and molecular evolution of the vaccine strain of type 3 poliovirus during the period of excretion by a primary vaccinee. J Gen Virol 67(4):693–706
Colson E, Racaniello V (1994) Soluble receptor-resistant poliovirus mutants identify surface and internal capsid residues that control interaction with the cell receptor. EMBO J 13(24):5855–5862
Kilpatrick DR et al (1998) Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol 36(2):352–357
Melnick J (1996) Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields BN, Knipe DM, Howley PM et al (eds) Fields virology, 3rd edn. Lippincott-Raven, Philadelphia, pp 655–712
Kilpatrick DR et al (2009) Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol 47(6):1939–1941
Rychlik W, Spencer WJ, Rhoads RE (1990) Optimization of the annealing temperature for DNA amplification in vitro. Nucleic Acids Res 18(21):6409–6412
Kilpatrick DR et al (2014) Identification of vaccine-derived polioviruses using dual-stage real-time RT-PCR. J Virol Methods 197:25–28
Kew OM et al (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59:587–635
Jegouic S et al (2009) Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses. PLoS Pathog 5(5):e1000412
Kew O et al (2002) Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296(5566):356–359
Martin J et al (2000) Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol 74(7):3001–3010
Shimizu H et al (2004) Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 78(24):13512–13521
Yakovenko ML et al (2006) Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J Virol 80(6):2641–2653
Burns C et al (2013) Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in Northern Nigeria. J Virol 87(9):4907–4922
Jorba J et al (2008) Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol 82(9):4429–4440
Kilpatrick DR et al (2011) Poliovirus serotype-specific VP1 sequencing primers. J Virol Methods 174(1–2):128–130
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Burns, C.C., Kilpatrick, D.R., Iber, J.C., Chen, Q., Kew, O.M. (2016). Molecular Properties of Poliovirus Isolates: Nucleotide Sequence Analysis, Typing by PCR and Real-Time RT-PCR. In: Martín, J. (eds) Poliovirus. Methods in Molecular Biology, vol 1387. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3292-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3292-4_9
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3291-7
Online ISBN: 978-1-4939-3292-4
eBook Packages: Springer Protocols